Yes, all suspected adverse reactions to Mounjaro should be reported via the Yellow Card Scheme, particularly serious reactions, those causing hospitalisation, or any reactions not documented in the Summary of Product Characteristics
Her background in metabolic strategy and women's health brings a thoughtful, holistic perspective to weight loss care combining medication with nutrition guidance and ongoing physician support
No, Lemme is not covered by insurance and does not qualify for HSA or FSA use
The post adds that GLP-1 therapy may raise serum uric acid through weight-loss-related shifts in purine metabolism
If youre looking for a more tailored approach to weight losswith medical guidance and ongoing support this limited-time discount could be worth considering
When semaglutide was tested in obesity trials, participants lost an average of about 15% of their body weightfar exceeding the results seen with earlier anti-obesity drugs